Skip to main content
Log in

Resource Utilisation and Time Commitment Associated with Correction of Anaemia in Cancer Patients Using Epoetin Alfa

  • Correspondence
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Meehan KR, Tchekmedyian NS, Smith RE, et al. Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa. Clin Drug Investig 2006; 26(10): 593–601

    Article  PubMed  Google Scholar 

  2. Fortner B, Tauer K, Zhu M, et al. The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver: a national survey. Commun Oncol 2004; 1: 211–7

    Article  Google Scholar 

  3. Langer CJ, Fastenau JM, Forlenza JB, et al. Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia. Curr Med Res Opin 2007; 23(1): 85–92

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have received an honorarium from Ortho Bio-tech Clinical Affairs, LLC, Bridgewater, NJ, USA for preparation of this letter.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lynch, DM., Slaven, T. Resource Utilisation and Time Commitment Associated with Correction of Anaemia in Cancer Patients Using Epoetin Alfa. Clin. Drug Investig. 27, 661–662 (2007). https://doi.org/10.2165/00044011-200727090-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200727090-00007

Keywords

Navigation